Drilldown: Medicines
Appearance
Medicines > onset
:
30–60 min
or
Slowing of cognitive decline over 18 months (modest effect, ~27% relative slowing) 
:
30–60 min
or
Slowing of cognitive decline over 18 months (modest effect, ~27% relative slowing) 
Use the filters below to narrow your results.
None (1) ·
Norepinephrine–dopamine reuptake inhibition (DAT, NET), d-threo enantiomer of methylphenidate (1) ·
Selective inhibitor of phosphodiesterase type 5 (PDE5), preventing cGMP breakdown in vascular smooth muscle. In the corpus cavernosum, potentiates the NO/cGMP cascade triggered by sexual stimulation. (1)
Showing below up to 3 results in range #1 to #3.

